Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -4.754% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. COCc1cc(C)nc2sc3c(=O)n(-c4cccc5ccccc45)nnc3c12
b. O=C(CCCSc1nc2ccccc2s1)NCc1ccco1
c. CC1Cc2nc(SCC(N)=O)n(Cc3ccccc3)c(=O)c2S1
Answer: c. CC1Cc2nc(SCC(N)=O)n(Cc3ccccc3)c(=O)c2S1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1Cc2nc(SCC(N)=O)n(Cc3ccccc3)c(=O)c2S1
CC1Cc2nc(SCC(N)=O)n(Cc3ccccc3)c(=O)c2S1
2-[(3-benzyl-6-methyl-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamide